Growth hormone secreting pituitary carcinoma: a case report and literature review.
Only five cases of growth hormone secreting pituitary carcinoma have been documented. We present a 49-year-old West Indian male with grossly elevated plasma growth hormone (760-10,400 mU/l), and a large aggressive pituitary tumour that continued to grow despite repeated pituitary surgery, radiotherapy and medical therapy (bromocriptine and somatostatin analogue). Thirteen years after diagnosis the patient died secondary to left ventricular failure. A post-mortem revealed a large locally invasive pituitary tumour, but in addition numerous tumour seedlings within the cerebrospinal fluid space, and a solitary intraparenchymal tumour deposit within the right temporal lobe, clearly separate from the primary tumour. Pituitary carcinoma should be considered in any acromegalic with grossly elevated plasma growth hormone levels who fails to respond to conventional therapy.
Stewart
P M
PM
Department of Medicine, University of Birmingham, General Hospital, UK.
Carey
M P
MP
Graham
C T
CT
Wright
A D
AD
London
D R
DR
D000172:Acromegaly / Q000209:etiology / Q000473:pathology; D002277:Carcinoma / Q000150:complications / Q000378:metabolism* / Q000473:pathology; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000150:complications / Q000378:metabolism* / Q000473:pathology
D013006:Growth Hormone